0
     

Report Added
Report already added
Top 5 Emerging Countries Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026

Top 5 Emerging Countries Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

The Emerging 5 Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: Sector size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the Sector.

Key Highlights

- These countries contributed $1,640.9 billion to the global healthcare providers industry in 2021, with a compound annual growth rate (CAGR) of 10.4% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $2,353.7 billion in 2026, with a CAGR of 7.5% over the 2021-26 period.
- Within the healthcare providers industry, China is the leading country among the top 5 emerging nations, with market revenues of $1,222.9 billion in 2021. This was followed by Brazil and India with a value of $227.3 and $93.6 billion, respectively.
- China is expected to lead the healthcare providers industry in the top five emerging nations, with a value of $1,795.5 billion in 2026, followed by Brazil and India with expected values of $301.5 and $129.9 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the emerging five healthcare providers Sector
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five healthcare providers Sector
- Leading company profiles reveal details of key healthcare providers Sector players’ emerging five operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the emerging five healthcare providers Sector with five year forecasts
- Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Reasons to Buy

- What was the size of the emerging five healthcare providers Sector by value in 2021?
- What will be the size of the emerging five healthcare providers Sector in 2026?
- What factors are affecting the strength of competition in the emerging five healthcare providers Sector?
- How has the Sector performed over the last five years?
- What are the main segments that make up the emerging five healthcare providers Sector?

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Healthcare Providers
2.1. Industry Outlook
3 Healthcare Providers in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Healthcare Providers in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Healthcare Providers in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Healthcare Providers in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Healthcare Providers in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Raffles Medical Group Ltd
13.2. Netcare Limited
13.3. UnitedHealth Group Incorporated
13.4. Diagnosticos da America SA
13.5. Fleury SA
13.6. IHH Healthcare Berhad
13.7. Chindex International Inc
13.8. Narayana Hrudayalaya Ltd
13.9. Apollo Hospitals Enterprise Ltd
13.10. Fortis Healthcare Ltd
13.11. KPJ Healthcare Berhad
13.12. Medica Sur SAB de CV
14 Appendix
14.1. Methodology
14.2. About MarketLine

List of Tables
Table 1: Top 5 emerging countries healthcare providers industry, revenue ($bn), 2017-26
Table 2: Top 5 emerging countries healthcare providers industry, revenue ($bn), 2017-21
Table 3: Top 5 emerging countries healthcare providers industry forecast, revenue ($bn), 2021-26
Table 4: South Africa healthcare providers sector value: $ billion, 2017-21
Table 5: South Africa healthcare providers sector category segmentation: $ billion, 2021
Table 6: South Africa healthcare providers sector geography segmentation: $ billion, 2021
Table 7: South Africa healthcare providers sector distribution: % share, by value, 2021
Table 8: South Africa healthcare providers sector value forecast: $ billion, 2021-26
Table 9: South Africa size of population (million), 2017-21
Table 10: South Africa gdp (constant 2005 prices, $ billion), 2017-21
Table 11: South Africa gdp (current prices, $ billion), 2017-21
Table 12: South Africa inflation, 2017-21
Table 13: South Africa consumer price index (absolute), 2017-21
Table 14: South Africa exchange rate, 2017-21
Table 15: Brazil healthcare providers sector value: $ billion, 2017-21
Table 16: Brazil healthcare providers sector category segmentation: $ billion, 2021
Table 17: Brazil healthcare providers sector geography segmentation: $ billion, 2021
Table 18: Brazil healthcare providers sector distribution: % share, by value, 2021
Table 19: Brazil healthcare providers sector value forecast: $ billion, 2021-26
Table 20: Brazil size of population (million), 2017-21
Table 21: Brazil gdp (constant 2005 prices, $ billion), 2017-21
Table 22: Brazil gdp (current prices, $ billion), 2017-21
Table 23: Brazil inflation, 2017-21
Table 24: Brazil consumer price index (absolute), 2017-21
Table 25: Brazil exchange rate, 2017-21
Table 26: China healthcare providers sector value: $ billion, 2017-21
Table 27: China healthcare providers sector category segmentation: $ billion, 2021
Table 28: China healthcare providers sector geography segmentation: $ billion, 2021
Table 29: China healthcare providers sector distribution: % share, by value, 2021
Table 30: China healthcare providers sector value forecast: $ billion, 2021-26
Table 31: China size of population (million), 2017-21
Table 32: China gdp (constant 2005 prices, $ billion), 2017-21
Table 33: China gdp (current prices, $ billion), 2017-21
Table 34: China inflation, 2017-21
Table 35: China consumer price index (absolute), 2017-21
Table 36: China exchange rate, 2017-21
Table 37: India healthcare providers sector value: $ billion, 2017-21
Table 38: India healthcare providers sector category segmentation: $ billion, 2021
Table 39: India healthcare providers sector geography segmentation: $ billion, 2021
Table 40: India healthcare providers sector distribution: % share, by value, 2021
Table 41: India healthcare providers sector value forecast: $ billion, 2021-26
Table 42: India size of population (million), 2017-21
Table 43: India gdp (constant 2005 prices, $ billion), 2017-21
Table 44: India gdp (current prices, $ billion), 2017-21
Table 45: India inflation, 2017-21
Table 46: India consumer price index (absolute), 2017-21
Table 47: India exchange rate, 2017-21
Table 48: Mexico healthcare providers sector value: $ billion, 2017-21
Table 49: Mexico healthcare providers sector category segmentation: $ billion, 2021
Table 50: Mexico healthcare providers sector geography segmentation: $ billion, 2021
Table 51: Mexico healthcare providers sector distribution: % share, by value, 2021
Table 52: Mexico healthcare providers sector value forecast: $ billion, 2021-26
Table 53: Mexico size of population (million), 2017-21
Table 54: Mexico gdp (constant 2005 prices, $ billion), 2017-21
Table 55: Mexico gdp (current prices, $ billion), 2017-21
Table 56: Mexico inflation, 2017-21
Table 57: Mexico consumer price index (absolute), 2017-21
Table 58: Mexico exchange rate, 2017-21
Table 59: Raffles Medical Group Ltd: key facts
Table 60: Raffles Medical Group Ltd: Annual Financial Ratios
Table 61: Raffles Medical Group Ltd: Key Employees
Table 62: Netcare Limited: key facts
Table 63: Netcare Limited: Annual Financial Ratios
Table 64: Netcare Limited: Key Employees
Table 65: UnitedHealth Group Incorporated: key facts
Table 66: UnitedHealth Group Incorporated: Annual Financial Ratios
Table 67: UnitedHealth Group Incorporated: Key Employees
Table 68: Diagnosticos da America SA: key facts
Table 69: Diagnosticos da America SA: Annual Financial Ratios
Table 70: Diagnosticos da America SA: Key Employees
Table 71: Fleury SA: key facts
Table 72: Fleury SA: Annual Financial Ratios
Table 73: Fleury SA: Key Employees
Table 74: IHH Healthcare Berhad: key facts
Table 75: IHH Healthcare Berhad: Annual Financial Ratios
Table 76: IHH Healthcare Berhad: Key Employees
Table 77: Chindex International Inc: key facts
Table 78: Chindex International Inc: Key Employees
Table 79: Narayana Hrudayalaya Ltd: key facts
Table 80: Narayana Hrudayalaya Ltd: Annual Financial Ratios

List of Figures
Figure 1: Top 5 emerging countries healthcare providers industry, revenue ($bn), 2017-26
Figure 2: Top 5 emerging countries healthcare providers industry, revenue ($bn), 2017-21
Figure 3: S Top 5 emerging countries healthcare providers industry forecast, revenue ($bn), 2021-26
Figure 4: South Africa healthcare providers sector value: $ billion, 2017-21
Figure 5: South Africa healthcare providers sector category segmentation: % share, by value, 2021
Figure 6: South Africa healthcare providers sector geography segmentation: % share, by value, 2021
Figure 7: South Africa healthcare providers sector distribution: % share, by value, 2021
Figure 8: South Africa healthcare providers sector value forecast: $ billion, 2021-26
Figure 9: Forces driving competition in the healthcare providers sector in South Africa, 2021
Figure 10: Drivers of buyer power in the healthcare providers sector in South Africa, 2021
Figure 11: Drivers of supplier power in the healthcare providers sector in South Africa, 2021
Figure 12: Factors influencing the likelihood of new entrants in the healthcare providers sector in South Africa, 2021
Figure 13: Factors influencing the threat of substitutes in the healthcare providers sector in South Africa, 2021
Figure 14: Drivers of degree of rivalry in the healthcare providers sector in South Africa, 2021
Figure 15: Brazil healthcare providers sector value: $ billion, 2017-21
Figure 16: Brazil healthcare providers sector category segmentation: % share, by value, 2021
Figure 17: Brazil healthcare providers sector geography segmentation: % share, by value, 2021
Figure 18: Brazil healthcare providers sector distribution: % share, by value, 2021
Figure 19: Brazil healthcare providers sector value forecast: $ billion, 2021-26
Figure 20: Forces driving competition in the healthcare providers sector in Brazil, 2021
Figure 21: Drivers of buyer power in the healthcare providers sector in Brazil, 2021
Figure 22: Drivers of supplier power in the healthcare providers sector in Brazil, 2021
Figure 23: Factors influencing the likelihood of new entrants in the healthcare providers sector in Brazil, 2021
Figure 24: Factors influencing the threat of substitutes in the healthcare providers sector in Brazil, 2021
Figure 25: Drivers of degree of rivalry in the healthcare providers sector in Brazil, 2021
Figure 26: China healthcare providers sector value: $ billion, 2017-21
Figure 27: China healthcare providers sector category segmentation: % share, by value, 2021
Figure 28: China healthcare providers sector geography segmentation: % share, by value, 2021
Figure 29: China healthcare providers sector distribution: % share, by value, 2021
Figure 30: China healthcare providers sector value forecast: $ billion, 2021-26
Figure 31: Forces driving competition in the healthcare providers sector in China, 2021
Figure 32: Drivers of buyer power in the healthcare providers sector in China, 2021
Figure 33: Drivers of supplier power in the healthcare providers sector in China, 2021
Figure 34: Factors influencing the likelihood of new entrants in the healthcare providers sector in China, 2021
Figure 35: Factors influencing the threat of substitutes in the healthcare providers sector in China, 2021
Figure 36: Drivers of degree of rivalry in the healthcare providers sector in China, 2021
Figure 37: India healthcare providers sector value: $ billion, 2017-21
Figure 38: India healthcare providers sector category segmentation: % share, by value, 2021
Figure 39: India healthcare providers sector geography segmentation: % share, by value, 2021
Figure 40: India healthcare providers sector distribution: % share, by value, 2021
Figure 41: India healthcare providers sector value forecast: $ billion, 2021-26
Figure 42: Forces driving competition in the healthcare providers sector in India, 2021
Figure 43: Drivers of buyer power in the healthcare providers sector in India, 2021
Figure 44: Drivers of supplier power in the healthcare providers sector in India, 2021
Figure 45: Factors influencing the likelihood of new entrants in the healthcare providers sector in India, 2021
Figure 46: Factors influencing the threat of substitutes in the healthcare providers sector in India, 2021
Figure 47: Drivers of degree of rivalry in the healthcare providers sector in India, 2021
Figure 48: Mexico healthcare providers sector value: $ billion, 2017-21
Figure 49: Mexico healthcare providers sector category segmentation: % share, by value, 2021
Figure 50: Mexico healthcare providers sector geography segmentation: % share, by value, 2021
Figure 51: Mexico healthcare providers sector distribution: % share, by value, 2021
Figure 52: Mexico healthcare providers sector value forecast: $ billion, 2021-26
Figure 53: Forces driving competition in the healthcare providers sector in Mexico, 2021
Figure 54: Drivers of buyer power in the healthcare providers sector in Mexico, 2021
Figure 55: Drivers of supplier power in the healthcare providers sector in Mexico, 2021
Figure 56: Factors influencing the likelihood of new entrants in the healthcare providers sector in Mexico, 2021
Figure 57: Factors influencing the threat of substitutes in the healthcare providers sector in Mexico, 2021
Figure 58: Drivers of degree of rivalry in the healthcare providers sector in Mexico, 2021

Report Title: Top 5 Emerging Countries Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2017-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline